KPV is a tripeptide fragment derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). It is widely studied in immunology and molecular biology research for its regulatory effects on inflammatory signaling pathways, particularly those involving nuclear factor kappa B (NF-κB).
In laboratory and preclinical research settings, KPV is examined for its influence on cytokine expression, immune cell signaling, and inflammatory response modulation. Its small size and targeted activity make it a useful research tool for studying peptide-based regulation of inflammation at the cellular level.
Research involving KPV focuses on molecular signaling mechanisms and immune modulation rather than therapeutic or clinical application.
